Kenji Sakamoto

Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention

Kenichi Tsujita, Seigo Sugiyama, Hitoshi Sumida et al. · Journal of the American College of Cardiology · 2015 · 432 citations

Percutaneous Coronary Intervention, Health Policy, Cardiovascular Disease +12

Incremental Prognostic Significance of Peripheral Endothelial Dysfunction in Patients With Heart Failure With Normal Left Ventricular Ejection Fraction

Eiichi Akiyama, Seigo Sugiyama, Yasushi Matsuzawa et al. · Journal of the American College of Cardiology · 2012 · 279 citations

Heart Failure, Cardiovascular Disease, Cardiac Mechanic +9

Peripheral Endothelial Function and Cardiovascular Events in High‐Risk Patients

Yasushi Matsuzawa, Seigo Sugiyama, Hitoshi Sumida et al. · Journal of the American Heart Association · 2013 · 178 citations · Full text

Pentraxin 3 Is a New Inflammatory Marker Correlated With Left Ventricular Diastolic Dysfunction and Heart Failure With Normal Ejection Fraction

Junichi Matsubara, Seigo Sugiyama, Toshimitsu Nozaki et al. · Journal of the American College of Cardiology · 2011 · 170 citations

Inflammation, Cardiomyopathy, Heart Failure +8

Cardiomyocyte Sirt (Sirtuin) 7 Ameliorates Stress-Induced Cardiac Hypertrophy by Interacting With and Deacetylating GATA4

Satoru Yamamura, Yasuhiro Izumiya, Satoshi Araki et al. · Hypertension · 2019 · 111 citations · Full text